WASHINGTON — A new bill from Sen. Elizabeth Warren (D-Mass.) proposes a novel solution to the problem of high drug prices: bringing the U.S. government into the drug manufacturing business.

Warren plans to introduce a new bill, the Affordable Drug Manufacturing Act, Tuesday with Rep. Jan Schakowsky (D-Ill.) that would mandate the creation of an Office of Drug Manufacturing, which would be tasked with ensuring generic drugs are available to consumers at accessible prices. Among the potential tools at the office’s disposal: making the drugs itself.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

    • I had the same experience with my not being able to open the STATNewsletters, a few times.

      The only way to get your ability to have the newsletters open is to go in and sign in again, using your email address and the password that you created for the STATnewletters.

      Then you will have to sign up again, for the several newsletters that you wanted and if you were interested in reading more of the STATPlus newsletters, add those to the list as you have to do with the ones that you already have done.

      It takes a few minutes, yet I am grateful to be able to do it again. It should definitely work after you must re-enter your information again.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy